Abstract
Several ginsenoside (Rb1, Rb2, Rc, Rd, Re, Rf, Rg1 and Rg3) are neuroprotective and antinociceptive agents. In this study, we assessed the effects of these ginsenosides following intracerebroventricular (i.c.v.) administration on the nociceptive behaviors induced by intrathecal injection of pro-inflammatory cytokines (tumor necrosis factor-a (TNF-α), interleukin-1β (IL-1β), and interferon-γ (IFN-γ)). The ginsenosides, Rb1, Rb2, Rc, Rd, Re, Rf and Rg1, significantly attenuated the nociceptive behavior induced by TNF-α, IL-1β, and IFN-γ injection, but ginsenoside-Rg3 did not. These results suggest that several ginsenosides may regulate the nociceptive processing induced by pro-inflammatory cytokines.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Attele, A. S., Wu, J. A., and Yuan, C. S., Ginseng pharmacology: multiple constituents and multiple actions. Biochem. Pharmacol., 58, 1685–1693 (1999).
Choi, S. E., Choi, S., Lee, J. H., Whiting, P. J., Lee, S. M., and Nah, S. Y., Effects of ginsenosides on GABA(A) receptor channels expressed in Xenopus oocytes. Arch. Pharm. Res., 26, 28–33 (2003a).
Choi, S. S., Han, E. J., Han, K. J., Lee, H. K., and Suh, H. W., Antinociceptive effects of ginsenosides injected intracerebroventricularly or intrathecally in substance P-induced pain model. Planta Med., 69, 1001–1004 (2003b).
Choi, S. S., Han, K. J., Lee, J. K., Lee, H. K., Han, E. J., Kim, D. H., and Suh, H. W., Antinociceptive mechanisms of orally administered decursinol in the mouse. Life Sci., 13, 73, 471–485 (2003c).
Choi, S. S., Lee, J. K., and Suh, H. W., Antinociceptive profiles of aspirin and acetaminophen in formalin, substance P and glutamate pain models. Brain Res., 7; 921, 233–239 (2001).
Chung, K. M., Lee, K. C., Song, D. K., Huh, S. O., Choi, M. R., Kim, Y. H., and Suh, H. W., Differential modulatory roles of cholera toxin and pertussis toxin in the regulation of pain responses induced by excitatory amino acids administered intrathecally in mice. Brain Res., 9; 867, 246–249 (2000).
Haley, T. J. and McCormick, W. G., Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br. J. Pharmacol. Chemother, 12, 12–15 (1957).
Hunt, S. P. and Mantyh, P. W., The molecular dynamics of pain control. Nat Rev Neurosci., 2, 83–91 (2001).
Hylden, J. L. and Wilcox, G. L., Intrathecal substance P elicits a caudally-directed biting and scratching behavior in mice. Brain Res., 217, 212–215 (1981).
Kim, D., Kim, M. A., Cho, I. H., Kim, M. S., Lee, S., Jo, E. K., Choi, S. Y., Park, K., Kim, J. S., Akira, S., Na, H. S., Oh, S. B., and Lee, S. J., A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J. Biol. Chem., 282, 1 4975–14983 (2007).
Kim, H. S., Oh, K. W., Rheu, H. M., and Kim, S. H., Antagonism of U-50,488H-induced antinociception by ginseng total saponins is dependent on serotonergic mechanisms. Pharmacol Biochem Behav., 42, 587–593 (1992).
Martucci, C., Trovato, A. E., Costa, B., Borsani, E., Franchi, S., Magnaghi, V., Panerai, A. E., Rodella, L. F., Valsecchi, A. E., Sacerdote, P., and Colleoni, M., The purinergic antagonist PPADS reduces pain related behaviours and interleukin-1beta, interleukin-6, iNOS and nNOS overproduction in central and peripheral nervous system after peripheral neuropathy in mice. Pain, 2007.
Mogil, J. S., Shin, Y. H., McCleskey, E. W., Kim, S. C., and Nah, S. Y., Ginsenoside Rf, a trace component of ginseng root, produces antinociception in mice. Brain Res., 792, 218–228 (1998).
Nah, J. J., Hahn, J. H., Chung, S., Choi, S., Kim, Y. I., and Nah, S. Y., Effect of ginsenosides, active components of ginseng, on capsaicin-induced pain-related behavior. Neuropharmacology, 39, 2180–2184 (2000).
Nemmani, K. V. and Ramarao, P., Ginsenoside Rf potentiates U-50, 488H-induced analgesia and inhibits tolerance to its analgesia in mice. Life Sci., 72, 759–768 (2003).
Radad, K., Gille, G, Liu, L., and Rausch, W. D., Use of ginseng in medicine with emphasis on neurodegenerative disorders. J. Pharmacol. Sci., 100, 175–186 (2006).
Reeve, A. J., Patel, S., Fox, A., Walker, K., and Urban, L., Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat. Eur. J. Pain., 4, 247–257 (2000).
Rhim, H., Kim, H., Lee, D. Y., Oh, T. H., and Nah, S. Y., Ginseng and ginsenoside Rg3, a newly identified active ingredient of ginseng, modulate Ca2+ channel currents in rat sensory neurons. Eur. J. Pharmacol., 436, 151–158 (2002).
Robertson, B., Xu, X. J., Hao, J. X., Wiesenfeld-Hallin, Z., Mhlanga, J., Grant, G., and Kristensson, K., Interferon-gamma receptors in nociceptive pathways: role in neuropathic pain-related behaviour. Neuroreport, 24; 8, 1311–1316 (1997).
Sala, F., Mulet, J., Choi, S., Jung, S. Y., Nah, S. Y., Rhim, H., Valor, L. M., Criado, M., and Sala, S., Effects of ginsenoside Rg2 on human neuronal nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther., 301, 1052–1059 (2002).
Seo, Y. J., Kwon, M. S., Shim, E. J., Park, S. H., Choi, O. S., and Suh, H. W., Changes in pain behavior induced by formalin, substance P, glutamate and pro-inflammatory cytokines in immobilization-induced stress mouse model. Brain Res. Bull., 71, 279–286 (2006).
Shim, E. J., Seo, Y. J., Kwon, M. S., Ham, Y. O., Choi, O. S., Lee, J. Y., Choi, S. M., and Suh, H. W., The intracerebroventricular kainic acid-induced damage affects animal nociceptive behavior. Brain Res. Bull., 73, 203–209 (2007).
Shin, Y. H., Jung, O. M., Nah, J. J., Nam, K. Y., Kim, C. Y., and Nah, S. Y., Ginsenosides that produce differential antinociception in mice. Gen Pharmacol., 32, 653–659 (1999).
Suh, H. W., Song, D. K., Huh, S. O., and Kim, Y. H., Effects of ginsenosides injected intrathecally or intracerebroventricularly on antinociception induced by beta-endorphin administered intracerebroventricularly in the mouse. Neuropeptides, 33, 101–106 (1999).
Suh, H. W., Song, D. K., Huh, S. O., and Kim, Y. H., Modulatory role of ginsenosides injected intrathecally or intracerebroventricularly in the production of antinociception induced by kappa-opioid receptor agonist administered intracerebroventricularly in the mouse. Planta Med., 66, 412–417 (2000).
Suh, H. W., Song, D. K., and Kim, Y. H., Effects of ginsenosides injected intrathecally or intracerebroventricularly on antinociception induced by morphine administrated intracerebroventricularly in the mouse. Gen Pharmacol., 29, 873–877 (1997).
Tachikawa, E., Kudo, K., Harada, K., Kashimoto, T., Miyate, Y., Kakizaki, A., and Takahashi, E., Effects of ginseng saponins on responses induced by various receptor stimuli. Eur. J. Pharmacol., 369, 23–32 (1999).
Tadano, T., Namioka, M., Nakagawasai, O., Tan-No, K., Matsushima, K., Endo, Y., and Kisara, K., Induction of nociceptive responses by intrathecal injection of interleukin-1 in mice. Life Sci., 65, 255–261 (1999).
Tsang, D., Yeung, H. W., Tso, W. W., and Peck, H., Ginseng saponins: influence on neurotransmitter uptake in rat brain synaptosomes. Planta Med., 51, 221–224 (1985).
Watkins, L. R., Wiertelak, E. P., Goehler, L. E., Smith, K. P., Martin, D., and Maier, S. F., Characterization of cytokine-induced hyperalgesia. Brain Res., 15; 654, 15–26 (1994).
Yoon, S. R., Nah, J. J., Shin, Y. H., Kim, S. K., Nam, K. Y., Choi, H. S., and Nah, S. Y., Ginsenosides induce differential antinociception and inhibit substance P induced-nociceptive response in mice. Life Sci., 62, PL 319–325 (1998).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seo, YJ., Kwon, MS., Choi, HW. et al. Intracerebroventricular gisenosides are antinociceptive in proinflammatory cytokine-induced pain behaviors of mice. Arch. Pharm. Res. 31, 364–369 (2008). https://doi.org/10.1007/s12272-001-1165-x
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-001-1165-x